Chapter 47 – Mucosal Vaccines: An Overview

[1]  G. Barton,et al.  Antigen receptor signaling and cell death resistance controls intestinal humoral response zonation , 2023, bioRxiv.

[2]  S. Lundin,et al.  Oral Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Generates Both Foxp3+CD25+ and Foxp3−CD25− CD4+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[3]  C. Elson,et al.  Oral Tolerance in Humans: Failure to Suppress an Existing Immune Response by Oral Antigen Administration , 2004, Annals of the New York Academy of Sciences.

[4]  L. Mayer,et al.  Failure to Induce Oral Tolerance in Crohn's and Ulcerative Colitis Patients: Possible Genetic Risk , 2004, Annals of the New York Academy of Sciences.

[5]  L. Mayer,et al.  Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. , 2004, Gastroenterology.

[6]  J. Mcghee,et al.  Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity1 , 2004, The Journal of Immunology.

[7]  Robert T. Chen,et al.  Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. , 2004, The New England journal of medicine.

[8]  J. Blanchard,et al.  Dynamics of Simian immunodeficiency virus‐specific cytotoxic T‐cell responses in tissues , 2003, Journal of medical primatology.

[9]  T. Popović,et al.  Pathology and pathogenesis of bioterrorism-related inhalational anthrax. , 2003, The American journal of pathology.

[10]  J. Peiris,et al.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome , 2003, The Lancet.

[11]  M. McElrath,et al.  HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals , 2003, Journal of Immunology.

[12]  I. Steinmetz,et al.  A Single Intratracheal Dose of the Growth Factor Fms-Like Tyrosine Kinase Receptor-3 Ligand Induces a Rapid Differential Increase of Dendritic Cells and Lymphocyte Subsets in Lung Tissue and Bronchoalveolar Lavage, Resulting in an Increased Local Antibody Production1 , 2003, The Journal of Immunology.

[13]  E. Butcher,et al.  Dendritic Cells Support Sequential Reprogramming of Chemoattractant Receptor Profiles During Naive to Effector T Cell Differentiation 1 , 2003, The Journal of Immunology.

[14]  B. Arulanandam,et al.  Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. , 2003, International immunopharmacology.

[15]  D. Chaplin,et al.  Isolated Lymphoid Follicle Formation Is Inducible and Dependent Upon Lymphotoxin-Sufficient B Lymphocytes, Lymphotoxin β Receptor, and TNF Receptor I Function1 , 2003, The Journal of Immunology.

[16]  J. Olivo-Marin,et al.  Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. , 2003, Immunity.

[17]  G. Glenn,et al.  Immunostimulant Patch Containing Heat-Labile Enterotoxin from Escherichia coli Enhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic Cells , 2003, Journal of Virology.

[18]  S. Endres,et al.  Mature Dendritic Cells Derived from Human Monocytes Within 48 Hours: A Novel Strategy for Dendritic Cell Differentiation from Blood Precursors1 , 2003, The Journal of Immunology.

[19]  E. Kunkel,et al.  CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. , 2003, The Journal of clinical investigation.

[20]  E. Kunkel,et al.  A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts 1 , 2003, The Journal of Immunology.

[21]  M. Marinaro,et al.  Zonula Occludens Toxin Acts as an Adjuvant through Different Mucosal Routes and Induces Protective Immune Responses , 2003, Infection and Immunity.

[22]  C. Czerkinsky,et al.  Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses 1 , 2003, The Journal of Immunology.

[23]  D. Taub,et al.  MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity , 2003 .

[24]  J. Holmgren,et al.  A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection , 2003, Journal of Virology.

[25]  T. Lehner,et al.  Prevention of mucosally induced uveitis with a HSP60‐derived peptide linked to cholera toxin B subunit , 2003, European journal of immunology.

[26]  Y. Takeda,et al.  Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit1 , 2003, The Journal of Immunology.

[27]  Y. Takeda,et al.  A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. , 2002, The Journal of infectious diseases.

[28]  L. Babiuk,et al.  The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization , 2002, Immunology.

[29]  R. Lynch,et al.  Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1 , 2002, The Journal of Immunology.

[30]  R. Daynes,et al.  The induction of systemic and mucosal immunity to protein vaccines delivered through skin sites exposed to UVB. , 2002, Vaccine.

[31]  J. Mestecky,et al.  Humoral immune responses to microbial infections in the genital tract. , 2002, Microbes and infection.

[32]  E. Kunkel,et al.  The Intestinal Chemokine Thymus-expressed Chemokine (CCL25) Attracts IgA Antibody-secreting Cells , 2002, The Journal of experimental medicine.

[33]  H. Liao,et al.  Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization , 2002, Journal of Virology.

[34]  T. Iwanaga,et al.  Identification of Multiple Isolated Lymphoid Follicles on the Antimesenteric Wall of the Mouse Small Intestine1 , 2002, The Journal of Immunology.

[35]  K. Mansfield,et al.  Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. , 2001, Blood.

[36]  H. Liao,et al.  Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization1 , 2001, The Journal of Immunology.

[37]  M. Nussenzweig,et al.  Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial lymphocytes , 2001 .

[38]  N. Mantis,et al.  Collaboration of epithelial cells with organized mucosal lymphoid tissues , 2001, Nature Immunology.

[39]  C. P. Quinn,et al.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.

[40]  A. Kantele,et al.  Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine. , 2001, Journal of reproductive immunology.

[41]  K. Schön,et al.  CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen1 , 2001, The Journal of Immunology.

[42]  N. Walters,et al.  Cutting Edge: Dichotomy of Homing Receptor Dependence by Mucosal Effector B Cells: αE Versus L-Selectin1 , 2001, The Journal of Immunology.

[43]  Dexiang Chen,et al.  Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization , 2001, Journal of Virology.

[44]  N. Walters,et al.  M cell-targeted DNA vaccination , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Russell,et al.  Long-term persistence and recall of immune responses in aged mice after mucosal immunization. , 2001, Oral microbiology and immunology.

[46]  Jie Yu,et al.  A plant-based multicomponent vaccine protects mice from enteric diseases , 2001, Nature Biotechnology.

[47]  W. Strober,et al.  Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis1 , 2001, The Journal of Immunology.

[48]  K. Rosenthal,et al.  Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract1 , 2001, The Journal of Immunology.

[49]  S. Muller,et al.  Immunization onto bare skin with heat‐labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge , 2001, Immunology.

[50]  J. Clements,et al.  Differential Biological and Adjuvant Activities of Cholera Toxin and Escherichia coli Heat-Labile Enterotoxin Hybrids , 2001, Infection and Immunity.

[51]  M. Marinaro,et al.  Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic Immunity1 , 2001, The Journal of Immunology.

[52]  E. Lavelle,et al.  The identification of plant lectins with mucosal adjuvant activity , 2001, Immunology.

[53]  D. Taub,et al.  RANTES Potentiates Antigen-Specific Mucosal Immune Responses1 , 2001, The Journal of Immunology.

[54]  M. Marinaro,et al.  Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. , 2000, The American journal of pathology.

[55]  C. Alving,et al.  Transcutaneous immunization: A human vaccine delivery strategy using a patch , 2000, Nature Medicine.

[56]  J. Berzofsky,et al.  Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL , 2000, The Journal of Immunology.

[57]  A. Krieg,et al.  CpG DNA is an effective oral adjuvant to protein antigens in mice. , 2000, Vaccine.

[58]  Simon C Watkins,et al.  Vaginal Mucosa Serves as an Inductive Site for Tolerance1 , 2000, The Journal of Immunology.

[59]  J. Mcghee,et al.  Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues , 2000, The Journal of Immunology.

[60]  C. Czerkinsky,et al.  Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. , 2000, International immunology.

[61]  Stuart B. Goodman,et al.  Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.

[62]  C. Alving,et al.  Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants , 2000, Infection and Immunity.

[63]  Antonio Lanzavecchia,et al.  Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming , 2000, European journal of immunology.

[64]  M. Murphey-Corb,et al.  Identification of SIV env‐specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta) , 2000, Journal of medical primatology.

[65]  C. Czerkinsky,et al.  Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[66]  M. Rennels.  The Rotavirus Vaccine Story: A Clinical Investigator's View , 2000, Pediatrics.

[67]  J. Mcghee,et al.  Alternate Mucosal Immune System: Organized Peyer’s Patches Are Not Required for IgA Responses in the Gastrointestinal Tract1 , 2000, The Journal of Immunology.

[68]  D. Chaplin,et al.  The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. , 1999, Science.

[69]  James J. Campbell,et al.  Human G Protein–Coupled Receptor Gpr-9-6/Cc Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-Expressed Chemokine–Mediated Chemotaxis , 1999, The Journal of experimental medicine.

[70]  B. Arulanandam,et al.  Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. , 1999, The Journal of infectious diseases.

[71]  J. Viney,et al.  Modulating dendritic cells to optimize mucosal immunization protocols. , 1999, Journal of immunology.

[72]  M. Jutila,et al.  Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. , 1999, Journal of immunology.

[73]  M. Kieny,et al.  Mucosal immunity and tolerance: relevance to vaccine development , 1999, Immunological reviews.

[74]  R. Holmdahl,et al.  Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. , 1999, Arthritis and rheumatism.

[75]  Y. Takeda,et al.  Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant. , 1999, Journal of immunology.

[76]  F. Ennis,et al.  IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. , 1999, Journal of immunology.

[77]  J. Berzofsky,et al.  Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Marinaro,et al.  Zonula Occludens Toxin Is a Powerful Mucosal Adjuvant for Intranasally Delivered Antigens , 1999, Infection and Immunity.

[79]  J. Lillard,et al.  Lymphotactin acts as an innate mucosal adjuvant. , 1999, Journal of immunology.

[80]  L. Williams,et al.  Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Dendritic Cell Localization , 1999, The Journal of experimental medicine.

[81]  M. Marinaro,et al.  IL-12 is an effective adjuvant for induction of mucosal immunity. , 1999, Journal of immunology.

[82]  M. Marinaro,et al.  Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. , 1999, Journal of immunology.

[83]  R. Alvarez,et al.  Differences in Immune Responses Induced by Oral and Rectal Immunizations with Salmonella typhi Ty21a: Evidence for Compartmentalization within the Common Mucosal Immune System in Humans , 1998, Infection and Immunity.

[84]  G. Mayrhofer,et al.  Lymphocyte-filled villi: comparison with other lymphoid aggregations in the mucosa of the human small intestine. , 1998, Gastroenterology.

[85]  D. Lu,et al.  Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV , 1998, Journal of Virology.

[86]  H. Davis,et al.  CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. , 1998, Journal of immunology.

[87]  C. Kensil,et al.  QS-21: a water-soluble triterpene glycoside adjuvant. , 1998, Expert opinion on investigational drugs.

[88]  C. Dupont,et al.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. , 1998, Immunity.

[89]  Z. Moldoveanu,et al.  CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. , 1998, Vaccine.

[90]  A. Mowat,et al.  Expanding dendritic cells in vivo enhances the induction of oral tolerance. , 1998, Journal of immunology.

[91]  H. Mohri,et al.  Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes , 1998, Journal of Virology.

[92]  H. Okamura,et al.  Regulation of interferon-γ production by IL-12 and IL-18 , 1998 .

[93]  M. Levine,et al.  Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato , 1998, Nature Medicine.

[94]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[95]  G. Matyas,et al.  Skin immunization made possible by cholera toxin , 1998, Nature.

[96]  E. Raz,et al.  Gene vaccination: plasmid DNA is more than just a blueprint. , 1998, Immunology today.

[97]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[98]  C. Elson,et al.  The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. , 1997, Journal of immunology.

[99]  R. Compans,et al.  Current options for vaccine delivery systems by mucosal routes , 1997 .

[100]  E. Partridge,et al.  Rectal Immunization for Induction of Specific Antibody in the Genital Tract of Women , 1997, Journal of Clinical Immunology.

[101]  D. Tang,et al.  Vaccination onto bare skin , 1997, Nature.

[102]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[103]  J. Holmgren,et al.  Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina , 1997, Infection and immunity.

[104]  J. Petersen,et al.  A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  T. Flanigan,et al.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women , 1997, Infection and immunity.

[106]  E. Butcher,et al.  Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. , 1997, The Journal of clinical investigation.

[107]  M. Marinaro,et al.  Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA Responses , 1997, The Journal of experimental medicine.

[108]  M. Fleisher,et al.  Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies , 1997, Cancer Immunology, Immunotherapy.

[109]  E. Peterson,et al.  Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge , 1996, Infection and immunity.

[110]  L. van Alphen,et al.  Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. , 1996, The Journal of infectious diseases.

[111]  H. Wolf,et al.  Anti‐inflammatory properties of human serum IgA: induction of IL‐1 receptor antagonist and FcαR (CD89)‐mediated down‐regulation of tumour necrosis factor‐alpha (TNF‐α) and IL‐6 in human monocytes , 1996 .

[112]  T. Olsson,et al.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[113]  T. Tanimoto,et al.  Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production , 1996 .

[114]  H. Staats,et al.  Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). , 1996, Journal of immunology.

[115]  E. Berg,et al.  A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. , 1996, Journal of immunology.

[116]  H. Greenberg,et al.  Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity , 1996, Science.

[117]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[118]  S. Michalek,et al.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit , 1996, Infection and immunity.

[119]  M. Marinaro,et al.  Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. , 1996, The Journal of infectious diseases.

[120]  G. Dougan,et al.  Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant , 1996, Infection and immunity.

[121]  J. Mcghee,et al.  Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. , 1996, Journal of immunology.

[122]  M. Marinaro,et al.  Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. , 1995, Journal of immunology.

[123]  S. Szu,et al.  Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. , 1995, The Journal of infectious diseases.

[124]  H. Mason,et al.  Oral immunization with a recombinant bacterial antigen produced in transgenic plants , 1995, Science.

[125]  C. Czerkinsky,et al.  Induction of compartmentalized B-cell responses in human tonsils , 1995, Infection and immunity.

[126]  M. Mazanec,et al.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.

[127]  J. Banchereau,et al.  Human circulating specific antibody‐forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers , 1995, European journal of immunology.

[128]  C. Czerkinsky,et al.  Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[129]  P. Chanda,et al.  Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. , 1994, AIDS research and human retroviruses.

[130]  S. Husby,et al.  Suppression of the immune response by nasal immunization. , 1994, Clinical immunology and immunopathology.

[131]  J. Banchereau,et al.  Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. , 1994, The Journal of clinical investigation.

[132]  C. Elson,et al.  Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. , 1994, Journal of immunology.

[133]  E. Butcher,et al.  Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. , 1994, Journal of immunology.

[134]  M. Eibl,et al.  Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. , 1994, Blood.

[135]  J. Kraehenbuhl,et al.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces , 1994, Infection and immunity.

[136]  J. Mcghee,et al.  Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines , 1993, Infection and immunity.

[137]  T. Issekutz,et al.  Expression of a protective intestinal immune response can be inhibited at three distinct sites by treatment with anti-alpha 4 integrin. , 1993, Journal of immunology.

[138]  J. Mcghee,et al.  Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues , 1993, The Journal of experimental medicine.

[139]  T. Lehner,et al.  T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[140]  E. Berg,et al.  α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 , 1993, Cell.

[141]  J. Holmgren,et al.  Cholera Toxin Enhances Alloantigen Presentation by Cultured Intestinal Epithelial Cells , 1993, Scandinavian journal of immunology.

[142]  B. Spangler,et al.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. , 1992, Microbiological reviews.

[143]  C. Kaetzel,et al.  Intracellular neutralization of virus by immunoglobulin A antibodies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[144]  N. Dimmock,et al.  Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited , 1992, Journal of virology.

[145]  J. Mcghee,et al.  Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. , 1992, Journal of immunology.

[146]  J. Banchereau,et al.  Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A , 1992, The Journal of experimental medicine.

[147]  T. Hirano,et al.  Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. , 1991, The Journal of clinical investigation.

[148]  J. Holmgren,et al.  Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. , 1991, Journal of immunology.

[149]  G. Trinchieri,et al.  Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.

[150]  P. Offit,et al.  Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection , 1991, Journal of virology.

[151]  J. Mcghee,et al.  Peyer's patch B cells with memory cell characteristics undergo terminal differentiation within 24 hours in response to interleukin-6. , 1991, Cytokine.

[152]  P. C. Lee,et al.  The N-terminal quarter of reovirus cell attachment protein sigma 1 possesses intrinsic virion-anchoring function. , 1990, Virology.

[153]  J. Mestecky,et al.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin , 1990, Infection and immunity.

[154]  A. Fattom,et al.  Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid , 1990, Infection and immunity.

[155]  A. Kantele.  Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. , 1990, Vaccine.

[156]  R. Coffman,et al.  Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5. , 1990, Journal of immunology.

[157]  W. Rubas,et al.  Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro. , 1990, Journal of microencapsulation.

[158]  S. Szu,et al.  Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid , 1990, Infection and immunity.

[159]  B. Forrest,et al.  Specific immune response in humans following rectal delivery of live typhoid vaccine. , 1990, Vaccine.

[160]  D. Rubin,et al.  CD8 lymphocyte subpopulations in Peyer's patches induced by reovirus serotype 1 infection. , 1990, Journal of immunology.

[161]  Yunus,et al.  Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up , 1990, The Lancet.

[162]  J. Mestecky,et al.  IgA subclasses of human colostral antibodies specific for microbial and food antigens. , 1989, Clinical and experimental immunology.

[163]  S. Clark,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[164]  M. Russell,et al.  Complement‐Fixing Properties of Human IgA Antibodies Alternative Pathway Complement Activation by Plastic‐Bound, But Not Specific Antigen‐Bound, IgA , 1989, Scandinavian journal of immunology.

[165]  T. Hirano,et al.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells , 1989, The Journal of experimental medicine.

[166]  I. Weissman,et al.  Identification of a murine Peyer's patch—specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α , 1989, Cell.

[167]  J. Mcghee,et al.  Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. , 1988, Journal of immunology.

[168]  T. Gajewski,et al.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. , 1988, Journal of immunology.

[169]  R. Coffman,et al.  The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation , 1988, Immunological reviews.

[170]  K. Hatch,et al.  Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component‐containing cells , 1988, Obstetrics and gynecology.

[171]  J. Mestecky.  The common mucosal immune system and current strategies for induction of immune responses in external secretions , 1987, Journal of Clinical Immunology.

[172]  R. Bassel-Duby,et al.  Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer , 1987, Journal of virology.

[173]  W. Paul,et al.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. , 1987, Science.

[174]  J. Mcghee,et al.  IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans , 1987 .

[175]  D. Rubin,et al.  Gut mucosal immunization with reovirus serotype 1/L stimulates virus- specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches , 1987, The Journal of experimental medicine.

[176]  R. Rowland,et al.  The number and distribution of lymphoid follicles in the human large intestine. , 1986, Journal of anatomy.

[177]  P. Brandtzaeg,et al.  Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. , 1986, Journal of immunology.

[178]  J. Holmgren,et al.  Intestinal Mucosal Memory and Presence of Memory Cells in Lamina Propria and Peyer's Patches in Mice 2 Years after Oral Immunization with Cholera Toxin , 1986, Scandinavian journal of immunology.

[179]  E. Sweeney,et al.  Lymphoglandular complexes of the colon: structure and distribution , 1986, Histopathology.

[180]  C. Elson,et al.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. , 1984, Journal of immunology.

[181]  T. Issekutz.  The response of gut-associated T lymphocytes to intestinal viral immunization. , 1984, Journal of immunology.

[182]  A. J. Rosner,et al.  Demonstration of M Cells in the Specialized Follicle‐Associated Epithelium Overlying Isolated Lymphoid Follicles in the Gut , 1984, Journal of leukocyte biology.

[183]  L. Hanson,et al.  Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. , 1984, The Journal of pediatrics.

[184]  J. Mestecky,et al.  Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. , 1984, Journal of immunology.

[185]  J. Griffiss,et al.  IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. , 1983, Journal of immunology.

[186]  P. Brandtzaeg.  THE SECRETORY IMMUNE SYSTEM OF LACTATING HUMAN MAMMARY GLANDS COMPARED WITH OTHER EXOCRINE ORGANS * , 1983, Annals of the New York Academy of Sciences.

[187]  R. Macdermott,et al.  Marked in vitro spontaneous secretion of IgA by human rib bone marrow mononuclear cells. , 1982, Journal of immunology.

[188]  J. Bienenstock,et al.  The effects of surgical removal of Peyer's patches in rat on systemic antibody responses to intestinal antigen. , 1981, Immunology.

[189]  M. Conley,et al.  Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens , 1980, The Journal of experimental medicine.

[190]  J. Bienenstock,et al.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. , 1979, Journal of immunology.

[191]  P. Gemski,et al.  The role of Peyer's patches in the local immune response of rabbit ileum to live bacteria. , 1978, Journal of immunology.

[192]  J. Mcghee,et al.  Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. , 1978, The Journal of clinical investigation.

[193]  M. E. Roux,et al.  Origin of IgA-secreting plasma cells in the mammary gland , 1977, The Journal of experimental medicine.

[194]  M. Mcwilliams,et al.  Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis , 1977, The Journal of experimental medicine.

[195]  M. Mcwilliams,et al.  Characteristics of mesenteric lymph node cells homing to gut-associated lymphoid tissue in syngeneic mice. , 1975, Journal of immunology.

[196]  S. Craig,et al.  Rabbit Peyer's patches, appendix, and popliteal lymph node B lymphocytes: a comparative analysis of their membrane immunoglobulin components and plasma cell precursor potential. , 1975, Journal of immunology.

[197]  P. Ogra.  Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. , 1971, The New England journal of medicine.

[198]  P. Ogra,et al.  Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. , 1968, The New England journal of medicine.

[199]  M. Allansmith,et al.  The development of immunoglobulinlevels in man , 1968 .

[200]  A. Kligman.  POISON IVY (RHUS) DERMATITIS , 1958 .

[201]  A. Kligman.  Poison ivy (Rhus) dermatitis; an experimental study. , 1958, A.M.A. archives of dermatology.

[202]  M. Chase,et al.  Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent , 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[203]  Tasuku Honjo,et al.  Intestinal IgA synthesis: regulation of front-line body defences , 2003, Nature Reviews Immunology.

[204]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[205]  Y. Wu,et al.  Gene transfer facilitated by a cellular targeting molecule, reovirus protein σ1 , 2000, Gene Therapy.

[206]  K. Matsushima,et al.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. , 1999, International immunology.

[207]  M. Kopf,et al.  Impaired mucosal immune responses in interleukin 4-targeted mice. , 1995, The Journal of experimental medicine.

[208]  K. Rosenthal,et al.  Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. , 1995, Vaccine.

[209]  C. Morrow,et al.  Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. , 1995, Vaccine.

[210]  R. Compans,et al.  Oral immunization with influenza virus in biodegradable microspheres. , 1993, The Journal of infectious diseases.

[211]  R. Pabst.  Is BALT a major component of the human lung immune system? , 1992, Immunology today.

[212]  J. Mcghee,et al.  The mucosal immune system: from fundamental concepts to vaccine development. , 1992, Vaccine.

[213]  J. Biewenga,et al.  The role of nasopharyngeal lymphoid tissue. , 1992, Immunology today.

[214]  J. Davin,et al.  The high lectin-binding capacity of human secretory IgA protects nonspecifically mucosae against environmental antigens. , 1991, Biology of the neonate.

[215]  Andreas Radbruch,et al.  Immunoglobulin class switching: molecular and cellular analysis. , 1990, Annual review of immunology.

[216]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[217]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[218]  J. Mcghee,et al.  Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. , 1987, Advances in immunology.

[219]  D. Alling,et al.  Basic Study and Laboratory Standardization , 1977 .